I grant Thermo Fisher (NYSE: TMO ) a buy rating. I am of the opinion that the company will experience higher revenue growth rates in the following years. The company reported headwinds in 2023 and 2024. However, in Q3 2025, its revenues increased byDaniel Mellado is an economist from Carabobo University with a Master's Degree in Statistics from Simon Bolivar University, both obtained in Venezuela.Daniel worked analyzing the agricultural commodity market and the financial investment portfolio for an agribusi ...